Peter Wijngaard - 24 Nov 2023 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

Role
Director
Signature
/s/ Peter Wijngaard
Issuer symbol
HEPA
Transactions as of
24 Nov 2023
Net transactions value
+$15,350
Form type
4
Filing time
28 Nov 2023, 06:55:05 UTC
Previous filing
20 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HEPA Common Stock Purchase $7,725 +2,500 +56% $3.09 7,001 24 Nov 2023 Direct
transaction HEPA Common Stock Purchase $7,625 +2,500 +36% $3.05 9,501 27 Nov 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.